Factor VIIi concentrates. Problems and protein chemistry characterization
Kröniger, A.; Kumpe, A.; Wormsbächer, W.; Herchenhahn, B.
Die Medizinische Welt 33(28): 1027-1033
1982
ISSN/ISBN: 0025-8512 PMID: 6811831 Document Number: 189942
Document emailed within 1 workday
Related Documents
Orthner, C.L. 1984: Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography Journal of Laboratory and Clinical Medicine 104(5): 816-828Yoshioka, A.; Shima, M.; Nishino, M.; Yoshikawa, N.; Fukui, H. 1987: In vitro characterization of various factor VIII concentrates Arzneimittel-Forschung 37(7): 753-756
Rosén, S. 2001: A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates Thrombosis and Haemostasis 86(4): 1132-1133
Allain, J.P. 1972: Study of the "in vivo" activity of factor VIIi or factor IX after injection of several concentrates: practical applications Nouvelle Revue Francaise d'Hematologie 12(2): 241-249
Vicente, V. 1989: Plasma concentrates of factor VIII. Where are we? Sangre 34(1): 1-3
Klarmann, D.; Kreuz, W.; Auerswald, G.; Auberger, K.; Rabenau, H.; Gürtler, L.; Roggendorf, M. 1995: Hepatitis C and pasteurised factor VIIi and IX concentrates Thrombosis and Haemostasis 73(4): 736-737
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247
Laurian, Y.; Dussaix, E.; Parquet, A.; Chalvon-Demersay, A.; d'Oiron, R.; Tchernia, G. 1994: Transmission of human parvovirus B19 by plasma derived factor VIIi concentrates Nouvelle Revue Francaise d'Hematologie 36(6): 449-453
Rodríguez Bueno, S.; Montoro Ronsano, J.B.; Martínez Sánchez, B.; Altisent Roca, C.; Tusell Puigvert, J.M. 1991: The administration of factor VIIi concentrates to hemophiliacs by continuous perfusion pump Medicina Clinica 96(10): 364-366
Mikaelsson, M.; Oswaldsson, U.; Nilsson, I.M. 1994: Potency and in vivo recovery of high purity factor VIII concentrates Thrombosis and Haemostasis 72(1): 160-161
Brown, J.E.; Carton, C.L.; Hougie, C. 1981: The effect of naturally occurring antibodies to factor VIIi on an immunoradiometric assay for factor VIIi coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIIi inhibit Journal of Laboratory and Clinical Medicine 97(1): 65-71
Kasper, C.K.; Kim, H.C.; Gomperts, E.D.; Smith, K.J.; Salzman, P.M.; Tipping, D.; Miller, R.; Montgomery, R.M. 1991: In vivo recovery and survival of monoclonal-antibody-purified factor VIII concentrates Thrombosis and Haemostasis 66(6): 730-733
Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Eich, S.; Kusch, M.; Grundmann, C.; Hanker, C.; Seitz, R.; König, H. 2003: Factor VIII determination in patient's plasma and concentrates: a novel test equally suited for both matrices Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 14(4): 347-353
Aznar, J.A.; Jorquera, J.I.; Peiró, A.; Garcia, I. 1984: The importance of corticoids added to continued treatment with Factor VIIi concentrates in the suppression of inhibitors in haemophilia a Thrombosis and Haemostasis 51(2): 217-221
Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830
Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832
Elykomov, V.A.; Tsalikhin, A.D. 1991: A uniform technique of one-stage factor VIII:C assay in cryoprecipitate and its concentrates. Part II (according to the results obtained by the group of the "Hemostasis Pathology Commission) Gematologiia i Transfuziologiia 36(11): 31-33
Tran, T.H.; Duckert, F. 1983: Dissociation of factor VIIi procoagulant antigen VIII:CAg and factor VIIi related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag Thrombosis and Haemostasis 50(2): 547-551
Mahasandana, C.; Patharathienskul, D.; Suvatte, V. 1993: Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management Southeast Asian Journal of Tropical Medicine and Public Health 24(Suppl 1): 106-112